Aleck Jones, PhD, is Co-Founder of Kindling Bio, a company dedicated to developing breakthrough therapies for children affected by cancer. With over 17 years of research experience in cancer biology and child health from leading biomedical institutions including University College London and King's College London, Aleck is passionate about bringing scalable impact and innovation to some of society's most vulnerable patients.